» Articles » PMID: 22033715

Single-shot Turbo Spin-echo Diffusion-weighted Imaging for Retinoblastoma: Initial Experience

Overview
Specialty Neurology
Date 2011 Oct 29
PMID 22033715
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Retinoblastoma may exhibit variable hyperintensities on DWI, resulting in different values in the ADC maps, depending on their histology and cellularity. However, EP-based DWI has susceptibility artifacts and image distortions, which make DWI of the orbit a challenging technique. The aim of this study was to investigate the feasibility of single-shot turbo spin-echo (HASTE) DWI in the evaluation of children with retinoblastoma and to assess the value of ADC maps in differentiating viable and necrotic tumor tissue.

Materials And Methods: Two radiologists assessed conventional MR images, DWI, and ADC maps of 17 patients with retinoblastoma (n = 17 eyes). Non-EP DWI was performed by using a HASTE sequence with b-values of 0 and 1000 s/mm(2). ADC values were measured for enhancing and nonenhancing tumor tissue. ADC maps were compared with histopathologic findings regarding tumor differentiation and viability.

Results: On DWI, vital tumor tissue showed hyperintensity with negligible intensity of surrounding vitreous. The difference in mean (range) ADC values between enhancing (1.03 [0.72-1.22] × 10(-3) mm(2) s(-1)) and nonenhancing (1.47 [0.99-1.80] × 10(-3) mm(2) s(-1)) parts of retinoblastoma was statistically significant (P < .0005). Nonenhancing tumor parts showed a significantly lower ADC compared with vitreous (2.67 [2.24-3.20]×10(-3) mm(2) s(-1)) (P < .0005) and subretinal fluid (2.20 [1.76-2.96] × 10(-3) mm(2) s(-1)) (P < .0005). Histopathologically, low ADC values (enhancing tumor part) correlated to viable tumor tissue, whereas intermediate ADC values (nonenhancing tumor parts) correlated to necrotic tumor tissue.

Conclusions: HASTE DWI allowed adequate characterization of retinoblastoma, and ADC is a helpful tool to differentiate viable and necrotic tumor tissue and might be valuable in monitoring the response to eye-preserving therapies.

Citing Articles

Role of apparent diffusion map in the evaluation of retinoblastoma.

Spadoni V, Conceicao T, Schaefer F, Ercolani D, Maestri M, Klaes A Arq Bras Oftalmol. 2024; 87(2):e20210435.

PMID: 38422355 PMC: 11575744. DOI: 10.5935/0004-2749.2021-0435.


Comparison of HASTE versus EPI-Based DWI for Retinoblastoma and Correlation with Prognostic Histopathologic Parameters.

Sharma M, Gupta A, Jana M, Kashyap S, Bakhshi S, Sharma S AJNR Am J Neuroradiol. 2024; 45(2):198-204.

PMID: 38176729 PMC: 11285979. DOI: 10.3174/ajnr.A8084.


Magnetic Resonance Imaging in the Clinical Care for Uveal Melanoma Patients-A Systematic Review from an Ophthalmic Perspective.

Jaarsma-Coes M, Klaassen L, Marinkovic M, Luyten G, Vu T, Ferreira T Cancers (Basel). 2023; 15(11).

PMID: 37296958 PMC: 10252038. DOI: 10.3390/cancers15112995.


A descriptive neuroimaging study of retinoblastoma in children: magnetic resonance imaging features.

Orman G, Huisman T Pol J Radiol. 2022; 87:e363-e368.

PMID: 35979155 PMC: 9373869. DOI: 10.5114/pjr.2022.118107.


T-staging of rectal cancer: Utility of single-shot turbo spin-echo diffusion-weighted imaging with T2-weighted images and fusion images.

Ogawa M, Urano M, Takaishi T, Kan H, Arai N, Takahashi H PLoS One. 2021; 16(4):e0249433.

PMID: 33882087 PMC: 8059798. DOI: 10.1371/journal.pone.0249433.


References
1.
Hamstra D, Galban C, Meyer C, Johnson T, Sundgren P, Tsien C . Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. J Clin Oncol. 2008; 26(20):3387-94. PMC: 3266717. DOI: 10.1200/JCO.2007.15.2363. View

2.
Sepahdari A, Aakalu V, Kapur R, Michals E, Saran N, French A . MRI of orbital cellulitis and orbital abscess: the role of diffusion-weighted imaging. AJR Am J Roentgenol. 2009; 193(3):W244-50. DOI: 10.2214/AJR.08.1838. View

3.
Muir K, Buchan A, von Kummer R, Rother J, Baron J . Imaging of acute stroke. Lancet Neurol. 2006; 5(9):755-68. DOI: 10.1016/S1474-4422(06)70545-2. View

4.
de Graaf P, Knol D, Moll A, Imhof S, Schouten-van Meeteren A, Castelijns J . Eye size in retinoblastoma: MR imaging measurements in normal and affected eyes. Radiology. 2007; 244(1):273-80. DOI: 10.1148/radiol.2441060456. View

5.
Wippold 2nd F, Perry A . Neuropathology for the neuroradiologist: rosettes and pseudorosettes. AJNR Am J Neuroradiol. 2006; 27(3):488-92. PMC: 7976948. View